Study Evaluating Biomarkers In Relapsed/Refractory Pediatric Solid Tumors
NCT00106353
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
71
Enrollment
INDUSTRY
Sponsor class
Conditions
Adenocarcinoma
Neoplasms
Interventions
DRUG:
Torisel
Sponsor
Pfizer